--- title: "随着临床验证和生物技术创新重新定义健康，胶原蛋白水解物市场预计到 2036 年将达到 30 亿美元" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/277933476.md" description: "全球胶原蛋白水解物市场预计将从 2026 年的 14 亿美元增长到 2036 年的 30 亿美元，年均增长率为 7.8%。这一增长受到向生物活性肽和发酵衍生替代品转变的推动，因为消费者对健康益处的临床验证提出了需求。该市场主要由动物来源主导，特别是在营养保健品领域，亚太地区，尤其是中国和日本，增长显著。主要参与者包括 Gelita AG 和 Rousselot，专注于生物活性成分和可持续实践" datetime: "2026-03-05T12:18:57.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277933476.md) - [en](https://longbridge.com/en/news/277933476.md) - [zh-HK](https://longbridge.com/zh-HK/news/277933476.md) --- # 随着临床验证和生物技术创新重新定义健康，胶原蛋白水解物市场预计到 2036 年将达到 30 亿美元 _**Collagen Hydrolysates Market Growth Fueled by Shift Toward Fermentation-Derived Alternatives, Bioactive Peptides, and "Beauty-from-Within" Trends**_ **NEWARK, DE / ACCESS Newswire / March 5, 2026 /** The global collagen hydrolysates sector is undergoing a profound transformation, transitioning from a generic supplement into a scientifically-backed "functional powerhouse" driven by clinical validation and a surge in sustainable biotechnology. According to the latest strategic outlook by Future Market Insights (FMI), the global **Collagen Hydrolysates Market** valued at **USD 1.4 Billion in 2026**\-is projected to reach **USD 3.0 Billion by 2036**, expanding at a robust **7.8% CAGR**. The report identifies a critical pivot: consumers and manufacturers are moving beyond basic gelatin to embrace bioactive, condition-specific peptides that offer targeted benefits for joint mobility, skin elasticity, and gut health. This evolution is spearheaded by a shift toward high-purity extraction technologies and the groundbreaking emergence of non-animal, fermentation-derived alternatives. **Get Access to the Full Report Sample: Explore detailed forecasts, segment insights, and competitive analysis:** https://www.futuremarketinsights.com/reports/sample/rep-gb-14908 **The Pivot to "Clinical Substantiation" and Sustainable Sourcing** A primary driver for this decade-long expansion is the "medicalization" of the supplement aisle. FMI notes that as "beauty-from-within" trends gain mainstream traction, consumers are demanding proof of efficacy. "Collagen is no longer just about marketing hype; it is now a delivery vehicle for proven health outcomes," notes a senior FMI analyst. "We are seeing a massive influx of IP-backed products where clinical trials measuring serum peptide levels are used to justify premium pricing. In early 2025, the FDA's GRAS Notice Inventory confirmation of fermentation-derived collagen has provided a massive regulatory green light for the vegan-friendly sector." **Segment Insights: The Power of Animal-Based Sources and Nutraceutical Dominance** - Animal-Based Segment (65.0% Share): This segment maintains a dominant stronghold due to established global supply chains and the cost-effective availability of Type I and III collagen from bovine and porcine sources. - Nutraceuticals (45.0% Share): Leading the application category, nutraceuticals are fueled by an aging global population seeking preventative measures for joint and bone health. - Powder Formats (48.0% Share): Powder remains the leading form due to its high solubility and versatility in sports nutrition and functional beverages, though gummies and liquid shots are seeing rapid growth in the "lifestyle" category. **Regional Performance: China and Japan Lead the High-Growth Frontier** While North America remains a center for clean-label innovation, the highest velocity of growth is concentrated in the Asia-Pacific region: - China (8.4% CAGR): Leading the global growth curve, China is modernizing its massive manufacturing base to meet international regulatory standards while satisfying surging domestic demand. - Japan (7.9% CAGR): Driven by a sophisticated aesthetic culture and a high elderly population, Japan prioritizes low-molecular-weight peptides with superior absorption rates. - United States (7.5% CAGR): Sustained by the integration of collagen into performance nutrition and the rise of biotech "challenger" brands focused on animal-free alternatives. **Competitive Landscape: IP Protection and Bioactive Ecosystems** The market is characterized by intense competition as legacy gelatin producers transition into "bioactive" ingredient specialists. **Key Players include:** Gelita AG, Rousselot (Darling Ingredients), PB Leiner, Wellnex (Nitta Gelatin Inc.), Geltor, Nippi Collagen, Garden of Life, Orgain, and Viscofan BioEngineering. Strategic highlights include **Rousselot's** recent European patent for its "Colartix" joint health matrix and **Geltor's** focus on "bio-designed" ingredients that allow iconic brands to build sustainable, animal-free products. As Kurt Seidensticker, Founder of Vital Proteins, suggests, "Manufacturing scalability and agility are now prerequisites for capturing mass-market adoption." **Unlock In-Depth Market Intelligence - Access the Full Report Now:** https://www.futuremarketinsights.com/reports/collagen-hydrolysates-market **Why FMI:** https://www.futuremarketinsights.com/why-fmi **Related Reports:** **Pet Cardiovascular Health Supplement Market:** https://www.futuremarketinsights.com/reports/pet-cardiovascular-health-supplement-market **Pet Joint Health Supplements Market:** https://www.futuremarketinsights.com/reports/pet-joint-health-supplements-market **Ready-To-Roll (RTR) Icings Market:** https://www.futuremarketinsights.com/reports/ready-to-roll-rtr-icings-market **Fish-Based Pet Food Market:** https://www.futuremarketinsights.com/reports/fish-based-pet-food-market **Europe Savory Ingredients Market:** https://www.futuremarketinsights.com/reports/europe-savory-ingredients-market **About Future Market Insights (FMI)** Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals. An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities. **For Press & Corporate Inquiries** **Rahul Singh** **AVP - Marketing and Growth Strategy** **Future Market Insights, Inc.** +91 8600020075 For Sales - sales@futuremarketinsights.com For Media - Rahul.singh@futuremarketinsights.com For web - https://www.futuremarketinsights.com/ **SOURCE:** Future Market Insights, Inc. View the original press release on ACCESS Newswire ### 相关股票 - [IBBQ.US](https://longbridge.com/zh-CN/quote/IBBQ.US.md) - [DAR.US](https://longbridge.com/zh-CN/quote/DAR.US.md) - [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md) ## 相关资讯与研究 - [百英生物 IPO：高层薪酬增长近三倍，境内毛利率有所下滑](https://longbridge.com/zh-CN/news/282558268.md) - [华深智药宣布融资 7.87 亿美元融资：DST 与赛诺菲加持](https://longbridge.com/zh-CN/news/282485033.md) - [诺令生物负重冲刺港交所，硬核技术难破盈利困局](https://longbridge.com/zh-CN/news/282278440.md) - [Cell：利用人工智能预测 RNA 在细胞中的活性](https://longbridge.com/zh-CN/news/282291567.md) - [中慧生物-B：德勤辞任核数师](https://longbridge.com/zh-CN/news/282603461.md)